The Effects of the FDA Warning on the Use of Droperidol by U.S. Emergency Physicians

OBJECTIVES: To determine if emergency physicians’ (EP) use of droperidol has changed since the United States Food and Drag Administration (FDA) warning of December 2001 concerning QT interval prolongation, torsade de pointes, and sudden death; and to query EP opinions regarding droperidol before and...

Descripción completa

Detalles Bibliográficos
Autores principales: Richards, John R., Weiss, Steven J., Bretz, Stephen W., Schneir, Aaron B., Rinetti, Dauna, Derlet, Robert W.
Formato: Texto
Lenguaje:English
Publicado: California Chapter of the American Academy of Emergency Medicine 2003
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906954/
https://www.ncbi.nlm.nih.gov/pubmed/20852711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906954/
https://www.ncbi.nlm.nih.gov/pubmed/20852711

Ejemplares similares